Blog

Placental-Derived Stem Cell Therapy for Premature Babies with Intestinal Disease

Premature babies have a very difficult start to life. Their bodies are not adequately prepared for life outside of the womb and they are vulnerable to a range of illnesses.

One of the most common illnesses suffered by premature babies is called necrotising enterocolitis. It is a life-threatening disease of the bowels, which affects about 10% of all pre-term babies.

Read More

Umbilical Cord Stem Cells Hold Potential in Pulmonary Fibrosis Treatment

Pulmonary Fibrosis is a potentially life-threatening condition caused by scarring of the lungs. It leads to a variety of dangerous complications including lung cancer, pulmonary hypertensions, pneumothorax, and respiratory failure.

A new study suggests that pulmonary fibrosis could be treated with umbilical cord stem cells. The study, titled “Extracellular vesicles derived from umbilical cord mesenchymal stromal cells alleviate pulmonary fibrosis by means of transforming growth factor-β signaling inhibition” was recently published in Stem Cell Research & Therapy.

Read More

Using Cord Blood MSCs to treat BPD in Premature Infants Shows Promising Results

The results of a Phase II clinical trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) have recently been published.

Bronchopulmonary dysplasia is a lung disease which affects newborn babies. It is particularly common in premature infants and babies with a low birth weight. Researchers believe that the condition is exacerbated by or caused by prolonged mechanical ventilation.

Read More

Using Placental Stem Cells to Treat In-Utero Patients with Spina Bifida

A research team from UC Davis Health has been working in collaboration with the Fetal Surgery Department at the medical campus in recent months. They are working together to launch a groundbreaking clinical trial which will treat in-utero patients suffering from a birth defect called spina bifida using placental stem cells.

Read More

Stem Cell Therapy, A New Multiple Sclerosis Breakthrough in 2021?

Multiple sclerosis (MS) is a devastating neurological disease that affects millions of people worldwide. It occurs when the protective layer that surround the brain’s nerve cells break down, interfering with the electrical impulses that travel along each nerve.

Read More

Umbilical Cord Stem Cells for Severely Ill COVID19 Patients

According to the latest statistics, only 60% of the patients with COVID-19 admitted to an intensive care unit will survive. The other 40% succumb to the virus, leaving behind devastated families and friends.

A group of Canadian researchers believes that umbilical cord blood stem cells could greatly improve the chances that these severely ill patients will survive.

Read More

Umbilical Cord Stem Cells Eased Dystrophic Epidermolysis Bullosa (RDEB) Symptoms

Researchers have already discovered that the mesenchymal stem cells (MSCs) contained within umbilical cord blood have remarkable regenerative properties. They are capable of repairing tissue, reducing inflammation, moderating the immune system and much more.

Read More

Footballer Ashley Cain's Daughter Receives Cord Blood Transplant to Treat Leukaemia

Professional footballer Ashley Cain was devastated when he discovered that his daughter Azaylia was diagnosed with leukaemia at only two months of age. Any child would struggle to beat leukaemia, let alone a tiny infant.

Read More

Study Reveals Placenta Injection May Alleviate the Painful Symptoms of Arthritis

Findings from a recent clinical trial suggest that an injection of placenta cells may dramatically reduce pain caused by arthritis. The researchers believe that the pain reducing effects of the injection may last for up to a year.

The treatment studied in the trial is called ReNu. It was developed by British-US biotechnology firm Organogensis. It uses cells obtained from a part of the placenta called the amnion. This tissue can be easily obtained as it is normally discarded after a child has been born.

Read More

Hematopoietic Stem Cell Transplants May Provide Long-Term Benefit for People with MS

A new study indicates that a combination of immunosuppression treatments and hematopoietic stem cell (HSCs) transplants may be able to stop disability progressing in people with multiple sclerosis (MS).

The research team found that the treatment prevented disability from worsening in 71% of test subjects. In an even more exciting development, they found that some patients saw the symptoms of their disability improve over the course of several years. The findings suggest that immunosuppression combined with stem cell transplants might form a viable treatment for some of the symptoms of MS. The study was published in January in the online issue of Neurology®, from the medical journal of the American Academy of Neurology.

Read More

Recent Posts